Jeffrey Ives - Profile and Investment Details

Investor Profile

Jeffrey Ives is a Venture Capital based in Cambridge, Massachusetts, United States with a diverse investment portfolio that includes companies such as iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics, Karyopharm Therapeutics, CRISPR Therapeutics, Kit Check, Advanced Cell DiagnosticsWave Life Sciences, IRLAB Therapeutics, Arvinas, Versartis, Edge Therapeutics, Alector, UNUM Therapeutics, Cara Therapeutics, Aptinyx, Awarepoint, Harpoon Therapeutics, CardioKinetix, Intarcia Therapeutics, Cogent Biosciences, Relypsa, Neurana Pharmaceuticals, Treato, Rallybio, ReViral, Afferent Pharmaceuticals, Karus Therapeutics, Principia Biopharma, Acumen Pharmaceuticals, Pearl Therapeutics, Access Biotechnology, ReShape Lifesciences, Catalyst Pharmaceuticals Partners, GluMetrics, Kalidex Pharmaceuticals, Oxford Immunotec, Orthogonal Neuroscience, IlluminOss Medical, Aviir, Kyruus, Renovacor, Glympse Bio, CuraSen Therapeutics, Pfizer, Inc., Access Closure, BioRelix, DiCE Molecules, Passage Bio, Qlaris Bio, Bayer, Technology Will Save Us, Neuronetics, AiCure, True North Therapeutics, TigerConnect, Dimension Therapeutics, Presidio Pharmaceuticals, Bellus Health, BrightInsight, Truveris, Iterum Therapeutics, astrocyte pharmaceuticals, ObsEva, Deciphera Pharmaceuticals, QPID Health, . Over time, Jeffrey Ives has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Jeffrey Ives is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Cybersecurity, Messaging, Women Founded, Enterprise Software, Life Science, Artificial Intelligence (AI), Analytics, Software, Biotechnology, Legal Tech, Neuroscience, Clinical Trials, Natural Language Processing, Research, Digital Health, Nanotechnology, Medical, Therapeutics, Machine Learning may find it worthwhile to explore potential connections with Jeffrey Ives, as their portfolio suggests a familiarity and interest in this area.

Understanding Jeffrey Ives’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.